Reduced Immunosuppressive Properties of Axitinib in Comparison with Other Tyrosine Kinase Inhibitors-Reference-Cited by-同舟云学术

Reduced Immunosuppressive Properties of Axitinib in Comparison with Other Tyrosine Kinase Inhibitors

Published:2013-06 Issue:23 Volume:288 Page:16334-16347
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Stehle Franziska,Schulz Kristin,Fahldieck Corinna,Kalich Jana,Lichtenfels Rudolf,Riemann Dagmar,Seliger Barbara

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference54 articles.

1. Metastatic renal cell carcinoma;Flanigan;Curr. Treat. Options Oncol,2003

2. Molecular analysis of mechanisms regulating drug sensitivity and the development of new chemotherapy strategies for genitourinary carcinomas;Naito;World J. Surg,2000

3. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma;Thompson;Clin. Cancer Res,2007

4. Renal cell carcinoma-induced immunosuppression: an immunophenotypic study of lymphocyte subpopulations and circulating dendritic cells;Porta;Anticancer Res,2007

5. Immunotherapy of renal cell carcinoma;Gouttefangeas;Cancer Immunol. Immunother,2007

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Cross‐Talks of Notch and VEGF to Tweak the EMT and EPT Dynamics in Triple Negative Breast Cancer Cells;Advanced Therapeutics;2024-09-10

2. A Senescence-Mimicking (Senomimetic) VEGFR TKI Side Effect Primes Tumor Immune Responses via IFN/STING Signaling;Molecular Cancer Therapeutics;2024-04-30

3. In vitro evaluation of the antitumor activity of axitinib in canine mammary gland tumor cell lines;Journal of Veterinary Science;2024

4. Correlation of the tumor escape phenotype with loss of PRELP expression in melanoma;Journal of Translational Medicine;2023-09-20

5. Idiopathic CD4+ T-lymphocytopaenia withFLT1mutation complicated by progressive multifocal leucoencephalopathy and EBV+ polymorphic lymphoproliferative disorder;BMJ Case Reports;2023-08